AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 191 min read$SEER

Horn David R. sold $15K of SEER

Horn David R. (PRESIDENT & CFO) sold 7,309 shares of Seer, Inc. (SEER) at $2.03 on 2026-08-18.

Original reporting
SEC EDGAR · Horn David R.
Published Aug 19, 2026, 10:59 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 11:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$SEER
Neutral
high confidence
Mentioned
$SEER
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SEERNeutralLow
01

Why it matters

The sale is small and does not indicate a change in insider confidence.

02

Market read

Routine insider sale with negligible market impact.

03

What to watch

None

Relevance 3/10Novelty 3/10Timing: filed Aug 19, 2026

Background

SEC Form 4 filing discloses insider transactions.

Company-level read

Ticker impact

$SEERNeutralHigh confidence
Context

President & CFO Horn David R. sold 7,309 shares of Seer, Inc. for $14,809.50 on Aug 18, 2026.

Expected impact

minimal to none

Evidence & confidence

The transaction size (~$15K) is trivial relative to market cap and typical trading volume.

Market effects

Sector

none

Regional

none

Global

none

Counterpoint

What could challenge this read

None

Key entities

  • Company
    Seer, Inc.

    Publicly traded US company (ticker SEER).

  • Insider
    Horn David R.

    President & CFO of Seer, Inc.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

SEER insider trading history →

Related articles

AUG 14
$SEERMedAI 8/10

Seer Inc. Q2 2026 Earnings: Revenue Misses $3.1 Million

Seer Inc. (Nasdaq: SEER) reported Q2 2026 revenue of $3.1 million, below consensus of $4.0 million, and a net loss of $0.31 per share versus a $0.22 loss expected. The company reaffirmed full-year 2026 revenue guidance of $16 million to $18 million. Shares fell about 2.78% after hours to $2.10.

sci-tech-today.com6 min
AUG 11
$SEERMedAI 8/10

Seer, Inc. (SEER): Results of Operations and Financial Condition

Seer, Inc. (SEER) filed an SEC Form 8-K — Results of Operations and Financial Condition. Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook REDWOOD CITY, Calif. – August 11, 2026 – Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial r

SEC EDGAR 8-K6 min
JUL 30
$SEERMedAI 8/10

Two Revised, Non-Binding Proposals Seek to Acquire All of Seer's Class A Shares

Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D. Rhea-AI Summary Seer (Nasdaq: SEER) confirmed receipt of two further revised, unsolicited, non-binding acquisition proposals for all outstanding shares of its Class A common stock. On July 28, 2026, the Radoff-JEC Group offered $2.55 per share in cash plus a contingent value right.

stocktitan.net4 min
JUL 7
$LUCYMedAI 8/10

Top Biotech Gainers: LUCY Shines, SEER Gets Takeover Offer, OFIX, ENOV Rally On CMS Update

Biotech gainers: Innovative Eyewear (LUCY) rose 63% after preliminary Q2 2026 net sales of ~$0.99M (+71% YoY) and new retail orders; Seer (SEER) jumped 35% on an unsolicited $2.45/share cash takeover proposal plus contingent value rights; Orthofix (OFIX) and Enovis (ENOV) gained 16%/15% after CMS withdrew reimbursement changes for non-invasive bone growth stimulators.

rttnews.com6 min